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Reconstruction of 60 Years of Chikungunya Epidemiology
in the Philippines Demonstrates Episodic and Focal
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Catherine B. Lago,5 Daisy Villa,6 Chonticha Klungthong,8 Ilya A. Tac-An,6 Stefan Fernandez,8 John Mark Velasco,5 Vito G. Roque Jr,7 Ananda Nisalak,8
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Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; and 9International Vaccine Institute, Seoul, Republic of Korea
Proper understanding of the long-term epidemiology of chikungunya has been hampered by poor surveillance. Outbreak years are
unpredictable and cases often misdiagnosed. Here we analyzed age-speciﬁc data from 2 serological studies (from 1973 and 2012) in
Cebu, Philippines, to reconstruct both the annual probability of infection and population-level immunity over a 60-year period
(1952–2012). We also explored whether seroconversions during 2012–2013 were spatially clustered. Our models identiﬁed 4 discrete
outbreaks separated by an average delay of 17 years. On average, 23% (95% conﬁdence interval [CI], 16%–37%) of the susceptible
population was infected per outbreak, with >50% of the entire population remaining susceptible at any point. Participants who se-
roconverted during 2012–2013 were clustered at distances of <230 m, suggesting focal transmission. Large-scale outbreaks of chi-
kungunya did not result in sustained multiyear transmission. Nevertheless, we estimate that >350 000 infections were missed by
surveillance systems. Serological studies could supplement surveillance to provide important insights on pathogen circulation.
Keywords. chikungunya; epidemiology; Philippines; modeling; serological study.
Chikungunya virus (CHIKV) is a mosquito-transmitted alpha-
virus. While infection is rarely fatal, disease manifestations can
be severe and last for many months [1].Outbreaks of chikungu-
nya have been recorded since the 18th century, with regular
sweeps from Africa to Southeast Asia observed over 40–50-
year cycles [2]. More recently, outbreaks have been observed
over wider geographical areas, and since 2010, autochthonous
transmission has been documented in 5 continents [1, 3].
Most recently, CHIKV was introduced into the Caribbean in
2013 and subsequently spread into mainland South America
and North America [4, 5].The source of the Caribbean outbreak
is unclear. However, genetic analyses link it to Asian genotype
strains circulating in the Philippines [6].
The long-term epidemiology of chikungunya within any loca-
tion is poorly understood. Outbreaks are largely unpredictable,
and local immunity levels at the start of an epidemic are usually
unknown except in regions where all individuals are naive to
CHIKV exposure. Globally, we do not know whether there are lo-
cations with stable sustained transmission that can act as viral
sources for outbreaks elsewhere. Understanding the historical in-
cidence of the disease from passive surveillance data is difﬁcult as
hospitals usually lack appropriate diagnostic assays to identify in-
fections. Cases are often misdiagnosed as dengue, which can be
found in the same communities and is transmitted by the same
vector [7]. Recently, it has been demonstrated that subclinical
CHIKV infections may be much more common than previously
thought andmay even represent the majority of infections, further
raising the prospect of undetected outbreaks or even undetected
sustained transmission over multiple years [6].
Individuals who become infected by CHIKV develop speciﬁc
antibodies to the virus that can be detected years later, using
plaque reduction neutralization tests (PRNTs) [8]. Seropreva-
lence studies can therefore be used to characterize the propor-
tion of the population that has been exposed to the virus at
some point. Furthermore, thorough analysis of age-speciﬁc se-
roprevalence patterns may potentially be used to reconstruct the
historical patterns of infection within a community. This pro-
vides a unique opportunity to characterize the long-term epide-
miology of a virus, something that has not been feasible from
traditional surveillance system approaches despite the substan-
tial burden of disease. Here, we used data from 2 studies
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conducted in the same community in the Philippines, 39 years
apart (in 1973 and 2012), to estimate the historical incidence of
CHIKV infection over a 60-year period [6, 8]. We also analyzed




Data for this study come from 2 seroprevalence studies con-
ducted in Cebu City, Philippines (2010 population, 870 000)
[9]. Cebu City is a large urban center located on the island of
Cebu, sandwiched between hills in the center of the island
and the sea (Figure 1A).
1973 Study
In 1973, Tesh et al performed neutralization assays, using up to
5 different arboviruses, including CHIKV, on human samples
from locations throughout Southeast Asia [8]. In Cebu city,
the samples came from a cross-sectional study conducted
among the general population during parasitological surveys.
Both the number tested and the number positive were available
in 10-year age groups (0–9, 10–19, 20–29, 30–39, 40–49, 50–59,
and ≥60 years; Figure 1B).
2012–2013 Study
Starting in 2012, we conducted a prospective fever cohort
study in Cebu City. Between March and May 2012, randomly
sampled individuals ≥6 months of age were enrolled into the
study [6]. Blood specimens were collected at enrollment (base-
line) and 1 year after enrollment. Participants were actively fol-
lowed for febrile illnesses. Reverse-transcription polymerase
chain reaction analysis was used to identify symptomatic
CHIKV infections in febrile individuals. PRNTs were used
to identify the presence of CHIKV-speciﬁc neutralizing anti-
bodies at baseline and after 1 year (Figure 1C). Detectable
PRNT50 titers (deﬁned as a titer ≥10 causing 50% reduction
in the number of CHIKV plaques) were considered to signify
past CHIKV infection. Further details on the cohort study are
provided by Yoon et al [6].
Reconstruction of the Annual Probability of Infection
For immunizing infections such as those due to CHIKV, age-
stratiﬁed serological surveys can be used to infer the history of
circulation in the community [10]. In such situations, the age of
individuals is an indicator of the cumulative time of potential
infection risk. Assuming that the risk of infection is age inde-
pendent, we used a likelihood framework to estimate the annual
probability of infection in the population (ie, the proportion of
the susceptible population infected per year) for each year be-
tween 1952 and 2012. A similar approach has been used to
characterize the transmission of measles virus, dengue virus,
and other pathogens [10–12]. We could not reliably estimate
the annual probability of infection before 1952, as there were in-
sufﬁcient individuals in our data set who were alive at the time.
Figure 1. A, Map of the Philippines, showing the location of Manila and Cebu.
B, Age and serostatus of participants in the 1973 study in Cebu. C, Age and seros-
tatus of participants in the 2012 study. Also included is the proportion of individuals
who seroconverted during 2012–2013.











Therefore, we assumed a constant probability of infection be-
tween 1932 and 1952 and that all individuals were susceptible
before 1932. Each individual contributed to estimates of the
probability of infection for the years between their birth and
the serosurvey. We ﬁt the model in a Bayesian Markov chain
Monte Carlo framework, using the RStan package in R [13].
Further details of the model can be found in the Supplementary
Materials (Text 1).
We compared a model with different annual probabilities
of infection (ie, outbreaks lasting 1 year) to models where out-
breaks lasted for 2, 3, 4, and 5 years and where the hazard
of infection over the entire analyzed period was constant. We de-
ﬁned an outbreak as an event in which at least 1% of the suscep-
tible population was infected over the outbreak period. The total
number of outbreaks per model iteration was therefore the total
number of periods with an estimated probability of infection of
>1%. The deviance information criterion (DIC) was used to com-
pare model ﬁt. DIC differences of <3 as compared to the best
model were considered good support for that model, whereas
DIC differences of >5 were considered weak support [14].
Susceptible Population Reconstruction
The level of CHIKV circulation within any year may depend on
the immunity in the population, which in turn depends on the
history of infection and the age structure of the population. For
each model iteration, we reconstructed the population-level im-
munity to chikungunya across the study period. For each year
from 1932, we used the model estimates of the annual probability
of infection to calculate the proportion of individuals in each
5-year age group who had ever been infected. We then used the
proportion of individuals within 5-year age groups from historical
census estimates to calculate the overall proportion of the
population that was susceptible to infection each year. Age-
speciﬁc population census estimates for the Philippines were
available in 1939, 1948, 1960, 1970, 1975, 1980, 1990, 1995,
2000, 2007, and 2010 from the Philippine National Census Ofﬁce.
In addition, population projections were available for 2015. We
assumed the population structure was unchanged in the years be-
fore the ﬁrst census. Linear interpolation was used to estimate the
population within each age group for years between census years.
Sensitivity Analysis
We could not reliably estimate annual infection probabilities
prior to 1952. To explore the sensitivity to our model to our as-
sumption of a constant force of infection in the 20 years prior to
1952, we repeated the analysis after assuming (1) complete sus-
ceptibility of the population in 1952 (ie, 0% probability of infec-
tion prior to 1952) and (2) a nonconstant force of infection
between 1932 and 1952, when a different probability of infec-
tion was estimated for each year in that period.
Spatial Dependence
To explore the spatial characteristics of CHIKV transmission,
we used the τ(d) clustering statistic to assess whether spatial
dependence existed between individuals who seroconverted
during 2012–2013 [15]. The τ(d) statistic estimates the relative
risk of 2 individuals who seroconverted during the year being
within distance d of each other relative to the probability of
any 2 individuals in the study being that distance apart. τ(d)
values of >1.0 suggest clustering of individuals at distance d.
Ninety-ﬁve percent conﬁdence intervals (CIs) were generated
through 500 bootstrap simulations. The estimator used for
τ(d) can be found in the Supplementary Materials (Text 2).
All analyses were conducted in the R programming language
[16].
Ethical Approval
Approval for the study was obtained from institutional review
boards at the Vicente Sotto Memorial Medical Center in
Cebu City and the Walter Reed Army Institute of Research.
Informed consent was obtained from all study participants.
Researchers from the Johns Hopkins Bloomberg School of Pub-
lic Health did not have access to personally identiﬁable data and
so did not engage in human subjects research.
RESULTS
The 1973 study had 150 individuals with both seroprevalence
results and age-group data available. Thirty-three (22%) of
these individuals were seropositive for CHIKV, although this
ranged from 6% for those aged <10 years to 42% for those
aged 40–49 years (Figure 1) [8]. The 2012 study had 853 partic-
ipants with baseline neutralizing antibody titers available [6].
Two individuals with detectable titers at baseline but no detect-
able titers after 1 year were excluded from the analysis, as we
could not conﬁdently determine their true historical infection
status. In total, 241 (28%) had PRNT titers at baseline indicating
a history of CHIKV infection. Strikingly, no one aged <14 years
(out of 294 cohort participants in that age group) had detectable
titers, suggesting negligible circulation of the virus during the 14
years prior to 2012.
The results from these 2 studies were combined to estimate
the annual probability of infection between 1952 and 2012.
Model realizations consisted of small numbers of outbreaks
spread over the evaluated period (Figure 2). We estimated a
mean of 3.1 outbreaks (95% CI, 3.0–4.0 outbreaks) over the
60 years, with a mean probability of infection among the sus-
ceptible population of 23% per outbreak (95% CI, 16%–37%).
The timing and size of the outbreaks were remarkably con-
sistent across model iterations. Fifty-ﬁve percent of model iter-
ations had an outbreak in 1968 or 1969, with a mean probability
of infection among the susceptible population of 18% (95%
CI, 10%–26%) during the outbreak. One hundred percent of
model iterations identiﬁed an outbreak in 1986, with a mean
probability of infection of 37% (95% CI, 26%–47%). Finally,
72% of model iterations identiﬁed an outbreak in 1993, with a
mean probability of infection of 14% (95% CI, 6%–23%). In











addition, we have previously reported that 106 study partici-
pants (12%) seroconverted during the 2012–2013 study, result-
ing in an estimated probability of infection among the
susceptible population of 17% for that period [6]. We found
that the proportion of the population that remained susceptible
never dropped below 50% after any of the outbreaks. On aver-
age, outbreaks in periods outside those described above were
only supported by 1.1% of model iterations. We also estimated
that 3.2% of the population in 1952 had previously been infect-
ed, suggesting there may have been CHIKV present prior to this
time. However, there were insufﬁcient individuals alive during
these years to estimate the timing and size of any outbreaks dur-
ing this period.
Outbreaks lasting 2 or 3 years were only slightly less supported
by the data than single-year outbreaks (Table 1). Both the mean
number of outbreaks between 1952 and 2012 and the mean prob-
ability of infection in each outbreak were the same in all 3 of these
models (Figure 3). Models with outbreaks lasting 4 or 5 years or
where there was a constant annual probability of infection over
the entire evaluated period ﬁt the data much worse.
Outbreaks of chikungunya have been detected in Southeast
Asia since the 18th century [2], although whether they made it
to the Philippines is unclear. We could not reliably estimate
annual infection probabilities prior to the 1950s, as there were in-
sufﬁcient individuals in our data set who were alive at the time.
Nevertheless, our model results were robust to different assump-
tions about incidence prior to 1952 (Supplementary Figure 1).
Figure 2. A, Model estimates of the annual probability of infection and the proportion of the population susceptible between 1952 and 2012. The gray lines represent 1000
randomly chosen model realizations. The dashed line and the dotted line represent the annual probability of infection and the susceptible population, respectively, for the same
single-model realization. The other 2 panels show the observed and model estimates of the number of seropositive individuals, by age group, for the 1973 (B) and 2012 (C)
studies.
Table 1. Deviance Information Criteria (DIC) for Models Estimating the
Probability of Infection Between 1952 and 2012
Model DIC
Model 1: annual hazard of infection 808
Model 2: hazard of infection fixed for 2-year periods 812
Model 3: hazard of infection fixed for 3-year periods 810
Model 4: hazard of infection fixed for 4-year periods 818
Model 5: hazard of infection fixed for 5-year periods 820
Model 6: constant hazard of infection over entire time series 1095
Models differed in how many hazards of infection were estimated, ranging from a different
hazard estimated for each year (model 1) to a single hazard measured for the entire time
series (model 6).











Individuals who seroconverted during 2012–2013 were 2.2
times (95% CI, 1.5–3.1 times) more likely to live within 50 m
of each other relative to the probability of any 2 study partici-
pants living within 50 m of each other (Figure 4). This fell to 1.7
times (95% CI, 1.2–2.3 times) for those living within 100 m of
each other. Signiﬁcant spatial dependence was observed at dis-
tances of up to 230 m. These ﬁndings demonstrate signiﬁcant
spatial structure to where infections occurred during the year,
which suggests outbreaks were driven by small-scale focal
transmission.
DISCUSSION
We have used 2 seroprevalence studies to reconstruct 60 years of
chikungunya epidemiology in Cebu city. Understanding the
burden of CHIKV infection in this setting has not previously
been possible, as local surveillance systems have not been
equipped to reliably capture cases, which can be easily misdiag-
nosed as other febrile infections, especially since appropriate di-
agnostic assays are often unavailable. Such gaps are neither
restricted to the Philippines nor to CHIKV, and the approaches
used could be applied elsewhere. Our study has demonstrated
that CHIKV transmission in this setting was characterized by
episodic outbreaks followed by years of absence of the virus
with less than half the population immune to the virus at any
time. In addition, individuals in a prospective cohort study
who seroconverted during 2012–2013 tended to live much clos-
er to each other than the study population in general, support-
ing focal transmission of the virus.
The outbreak years identiﬁed in our model were consistent
with historical reports of chikungunya cases in Cebu or in
other parts of the Philippines. In particular, our model identi-
ﬁed an outbreak in 1986, the same year that a US Peace Corps
volunteer stationed in Cebu received a diagnosis of CHIKV
infection [17]. We estimated that nearly 40% of susceptible in-
dividuals were infected during this outbreak. The population of
Cebu City at the time was around 600 000 individuals, of whom
we estimate that 125 000 were immune, owing to previous out-
breaks. The size of the 1986 outbreak therefore translates to ap-
proximately 190 000 infections. It is surprising that the only
historical record of this outbreak was in a foreign visitor. We
also identiﬁed an outbreak in 1968–1969 with an estimated
size equivalent to 135 000 infections in Cebu City, coinciding
with a historical outbreak investigation in 1968 that reported
hospitalized chikungunya cases in Negros, an island next to
Cebu but with no cases reported in Cebu itself [18]. Finally,
we identiﬁed an outbreak in 1993 with an estimated size equiv-
alent to 32 000 infections in Cebu City. Although there were no
reports of chikungunya in Cebu during that time, an outbreak
was reported by a ﬁeld epidemiology training program ofﬁcer
on Cavite in northern Philippines in 1996, suggesting that the
virus was circulating in the country around that period [18, 19].
Aside from the reports mentioned above, we found no additional
Figure 3. Models that incorporate a different probability of infection every year
(solid), every 2 years (dashed), and every 3 years (dotted) are approximately equally
supported by the data. However, within these models, those that had longer-lasting
outbreaks also had lower annual probabilities of infection, so the total probability of
infection over the entire outbreak remained unchanged. A, Mean probability of in-
fection during outbreaks for the 3 models. Only years when at least 10% of iterations
had an outbreak in that year are shown. B, Mean total number of outbreaks. C, Mean
annual infection probability in an outbreak in the 3 model formulations. D, Mean
total probability of infection during an outbreak.
Figure 4. Spatial dependence among individuals who seroconverted during
2012–2013. The figure shows the results of τ(d) and represents the probability
that 2 individuals who seroconverted during 2012–2013 lived within distance d of
each other relative to the probability that any 2 individuals in the study lived that
distance apart.











historical reports of chikungunya cases in the Philippines over
the study period.
While limited surveillance capabilities likely contributed to
the apparently large number of unreported infections during
past outbreaks, there may also have been substantial levels of
subclinical or only mildly symptomatic infections. Macasaet
et al reported a high proportion of mildly symptomatic patients
in the 1968 outbreak, and this was also observed in the prospec-
tive cohort study in Cebu city in 2012–2013 [6, 18, 20]. The rea-
son that this population may have had lower proportions of
symptomatic disease than reported in other studies is unclear
[21, 22]. Viral factors may play a role including genotype- and
strain-speciﬁc effects. It appears likely that CHIKV lineages cir-
culating in this region throughout the study period were con-
served Asian genotype strains [3, 23]. Animal models have
suggested increased symptomatic disease in Indian Ocean
strains as compared to Asian strains [24, 25]. An alternative ex-
planation could be cross-protection generated from prior infec-
tion by other alphaviruses. Tesh et al did not ﬁnd any evidence
of historic Sindbis or Ross River virus infection in the 1973
study. However, a 1953 serostudy in the Manila area found
15% seropositivity to another alphavirus, Semliki Forest virus
[8, 26]. Other viruses may also exist. The role of human genetic
factors may also require further investigation.
We found that CHIKV transmission was episodic in nature
and followed by long absences, as evidenced by the small num-
ber of years for which we estimated nonzero probabilities of in-
fection. These patterns are consistent with reemergence driven
by reintroduction of virus, rather than with continuous low lev-
els of undetected human infection. Sources of viral introduction
are unclear but could be other communities in Southeast Asia.
Mainland settings with different travel patterns than that in the
island communities of Philippines may observe more regular
introductions. Alternatively, nonprimate populations in the
Philippines have been found with antibodies against CHIKV
and may act as a source [27], although other nonhuman primate
populations in nearby Borneo were not found to have been ex-
posed [28]. Comparisons of sequences obtained from humans
and primates could help us understand whether a sylvatic
cycle is important here. We found that over half the population
remained susceptible at any time point. Climatic or other envi-
ronmental factors may also have been important contributors to
CHIKV extinctions. No symptomatic cases were detected in the
prospective cohort study during the drier months of January to
May 2013 despite continued active surveillance, suggesting that
the virus was not in widespread circulation during periods with
low precipitation and limited mosquito activity. In other set-
tings with different environmental conditions, different tempo-
ral patterns of virus circulation may be present. In particular,
there remains an ongoing chikungunya epidemic in the Carib-
bean and the Americas due to a virus closely linked to one from
the Philippines [5, 6]. For settings that are comparable to Cebu
city, our ﬁndings suggest that epidemics in individual commu-
nities will not lead to sustained endemic transmission. However,
without a better understanding of the key factors underlying the
introduction and maintenance of the virus, there remains much
uncertainty about the future course of the outbreak.
It is tempting to use the estimates of the size of the outbreaks
to obtain estimates of the basic reproduction number for
CHIKV. The basic reproduction number, which represents
the number of infections caused by a single infectious individ-
ual in a completely susceptible population, is sought after as it
provides insight into the transmissibility of the pathogen and is
linked to vaccine coverage required to control spread (if a vac-
cine were to become widely available). However, epidemic-ﬁnal-
size approaches assume that epidemics cease solely because of
depletion of susceptible individuals and, in this circumstance,
may therefore underestimate the true basic reproduction num-
ber. Such an approach yields estimates of 1.1–1.3 across the 4
outbreaks, lower than previously reported values from other set-
tings (values of up to 6.5 have been proposed; Supplementary
Text 3) [5, 29].
We found that seroconversions in 2012–2013 were spatially cor-
related at distances of <230 m, consistent with transmission events
centering in or near the home. Similar approaches with dengue
have shown that dengue cases in both urban and rural environ-
ments in Thailand cluster at greater distances (up to 1 km) [15,
30]. However, dengue virus is in endemic circulation in these lo-
cations, and sustained transmission can lead to much larger foot-
prints of spatial dependence than in isolated outbreaks. These
ﬁndings suggest that targeted effective interventions at the neigh-
borhood scale could potentially reduce CHIKV infection risk.
Our models could not discriminate between outbreaks lasting
1, 2, or 3 years. However, outbreaks lasting for >3 years were not
supported by our data. Estimates of the total size of outbreaks
remained unchanged. In the 1973 study, ages were only avail-
able in 10-year age groups, reducing the precision with which
we could estimate the probability of infection during the
1950s and 1960s. Differences in risk of infection by age may
have inﬂuenced our estimates. However, we did not observe
any large-scale differences in risk, stratiﬁed by age, for those
who seroconverted in 2012–2013, suggesting any differences
were likely to be minor (Supplementary Figure 2). The long-
term trajectories of antibody levels following infection remain
poorly understood, although high titers have been recorded
19 years after a recorded outbreak [31]. If antibodies become
undetectable after long periods, this would limit our ability to
identify outbreaks in the distant past. However, where detected,
neutralization titers were generally high (median PRNT50 of
841), and we observed no statistical difference in titer stratiﬁed by
age (Supplementary Figure 3). In addition, we did not identify any
symptomatic infections in individuals with detectable PRNT50 ti-
ters at baseline during active follow-up in 2012–2013, irrespective
of how low titers were. Taken together, these observations











suggest that any waning was minimal and that there was unlike-
ly to be any loss of immune protection after infection.
CHIKV transmission appears to be episodic and focal in this
setting, with over half of the population in Cebu City remaining
susceptible to infection throughout the study period. This study
highlights the usefulness of age-speciﬁc seroprevalence studies
in efforts to understand the long-term epidemiology of patho-
gens such as CHIKV, especially in settings where surveillance
systems may not be able to reliably capture cases. Incorporating
systematic serological investigations into health systems could
allow improved disease surveillance.
Supplementary Data
Supplementary materials are available at http://jid.oxfordjournals.org.
Consisting of data provided by the author to beneﬁt the reader, the posted
materials are not copyedited and are the sole responsibility of the author, so
questions or comments should be addressed to the author.
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